Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanara MedTech Inc. Director's Dealing 2013

Jun 3, 2013

33339_dirs_2013-06-03_cdc77d6a-a81e-4817-bc7d-8ea43195f6c0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WOUND MANAGEMENT TECHNOLOGIES, INC. (WNDM)
CIK: 0000714256
Period of Report: 2008-07-14

Reporting Person: COSSUTTA ARALDO A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-07-14 Common Stock J 503448 Acquired 5518448 Direct
2008-11-11 Common Stock G 115000 Disposed 5274214 Direct
2008-11-11 Common Stock G 65000 Disposed 5274214 Direct
2008-11-11 Common Stock G 44234 Disposed 5274214 Direct
2008-11-11 Common Stock G 20000 Disposed 5274214 Direct
2008-12-16 Common Stock S 5000 $3.25 Disposed 5269214 Direct
2008-12-19 Common Stock S 500 $3.05 Disposed 5268714 Direct
2008-12-22 Common Stock S 623 $3.25 Disposed 5268091 Direct
2012-12-23 Common Stock S 8877 $3 Disposed 5259214 Direct
2009-09-09 Common Stock J 200000 Acquired 5459214 Direct
2009-09-30 Common Stock J 525000 Acquired 5984214 Direct
2010-11-04 Common Stock J 50000 Acquired 6034214 Direct
2010-11-04 Common Stock G 15786 Acquired 6050000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-07-27 Warrant $0.15 J 75000 Acquired 2017-07-27 Common Stock (75000) Direct
2012-09-11 Warrant $0.15 A 52000 Acquired 2017-09-30 Common Stock (52000) Direct

Footnotes

F1: Mr. Cossutta received these shares of Common Stock in repayment of various loans made by Mr. Cossutta to the Issuer between September 30, 2004 and October 15, 2007 in total principal amount of $717,000 plus accrued interest.

F2: These shares were a bona fide gift to a non-cohabitating family member.

F3: These shares were a bona fide gift to Mr. Cossutta from another shareholder.

F4: These warrants were issued in connection with a Subordinated Promissory note transaction pursuant to which Mr. Cossutta loaned the principal amount of $75,000 to the Company and acquired 75,000 warrants (1 warrant for every $1 of principal loaned) as part of the aforementioned transaction at no additional consideration.

F5: The board of directors of the Issuer (the "Board") approved the issuance of these warrants at a meeting of the Board on September 11, 2012 as compensation for Mr. Cossutta's service as a director on the Board of the Issuer.